Immunovia AB ( ($SE:IMMNOV) ) has issued an update. Immunovia has announced that its analytical validation study of PancreaSure, a blood-based ...
Producing cGMP biopharmaceutical products requires controlled, consistent performance of the manufacturing process. cGMP also requires controlled, consistent performance of analytical test methods.
In the 1980s, the human immunodeficiency virus (HIV) was a global scourge, decimating communities. When it was identified in the blood products supply chain, people were terrified.